🌎 PTC Therapeutics Upgraded, Logitech International Upgraded, Xenon Pharmaceuticals Initiated and more…
RJ Hamster
Advertisements
Ratings changes for Intapp, Galmed Pharmaceuticals, Intra-Cellular Therapies, Aethlon Medical, Bridgeline Digital, Evoke Pharma, United-Guardian and more…Upgrade to MarketBeat All Access to get early delivery, personalized stock alerts, portfolio monitoring tools, and more.  Start Your Free Trial.
Elon Warns of $36T Crisis – Trump Scrambling For A Fix (ad)
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of collapse and built two of the most valuable companies in history.
Now, he’s sounding the alarm about America’s $36 trillion debt time bomb that could destroy the fabric of our society.As head of the Department of Government Efficiency (DOGE) under President Trump, Musk is exposing just how bad things are…
insider Bradford L. Smith sold 75,000 shares of the company’s stock in a transaction dated Friday, May 2nd. The shares were sold at an average price of $436.05, for a total transaction of $32,703,750.00. Following the completion of the transaction, the insider now owns 476,999 shares of the company’s stock, valued at $207,995,413.95. This represents a 13.59 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link.
insider Bradford L. Smith sold 6,000 shares of Microsoft stock in a transaction that occurred on Monday, May 5th. The stock was sold at an average price of $433.17, for a total transaction of $2,599,020.00. Following the sale, the insider now directly owns 471,036 shares in the company, valued at $204,038,664.12. The trade was a 1.26 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Albertsons Companies (NYSE:ACI) was upgraded by analysts at BMO Capital Markets from a “market perform” rating to an “outperform” rating. They now have a $25.00 price target on the stock, up previously from $19.00. This represents a 11.7% upside from the current price of $22.37.
Aegon (NYSE:AEG) was upgraded by analysts at BNP Paribas Exane from a “neutral” rating to an “outperform” rating.The current price is $6.73.
Advanced Micro Devices (NASDAQ:AMD) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $120.00 price target on the stock. This represents a 20.3% upside from the current price of $99.72.
Amylyx Pharmaceuticals (NASDAQ:AMLX) was upgraded by analysts at Leerink Partners from a “market perform” rating to an “outperform” rating. They now have a $10.00 price target on the stock, up previously from $4.00. This represents a 100.2% upside from the current price of $5.00.
CuriosityStream (NASDAQ:CURI) was upgraded by analysts at Barrington Research from a “market perform” rating to an “outperform” rating. They now have a $6.00 price target on the stock. This represents a 17.3% upside from the current price of $5.11.
Electronic Arts (NASDAQ:EA) was upgraded by analysts at HSBC Holdings plc from a “hold” rating to a “buy” rating. They now have a $190.00 price target on the stock. This represents a 21.3% upside from the current price of $156.69.
Honeywell International (NASDAQ:HON) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $250.00 price target on the stock. This represents a 16.9% upside from the current price of $213.86.
Logitech International (NASDAQ:LOGI) was upgraded by analysts at UBS Group AG from a “neutral” rating to a “buy” rating.The current price is $77.31.
Louisiana-Pacific (NYSE:LPX) was upgraded by analysts at Loop Capital from a “hold” rating to a “buy” rating. They now have a $110.00 price target on the stock. This represents a 22.1% upside from the current price of $90.08.
Otter Tail (NASDAQ:OTTR) was upgraded by analysts at Siebert Williams Shank from a “hold” rating to a “buy” rating. They now have a $83.00 price target on the stock, up previously from $82.00. This represents a 9.3% upside from the current price of $75.95.
PTC Therapeutics (NASDAQ:PTCT) was upgraded by analysts at Citigroup Inc. from a “sell” rating to a “neutral” rating. They now have a $40.00 price target on the stock, down previously from $50.00. This represents a 2.5% upside from the current price of $39.01.
Constellation Brands (NYSE:STZ) was upgraded by analysts at Truist Financial Co. from a “hold” rating to a “buy” rating. They now have a $215.00 price target on the stock. This represents a 13.7% upside from the current price of $189.13.
Wynn Resorts (NASDAQ:WYNN) was upgraded by analysts at Bank of America Co. from a “neutral” rating to a “buy” rating. They now have a $100.00 price target on the stock. This represents a 21.1% upside from the current price of $82.60.
Is there anybody more powerful than Donald Trump right now?
In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones…
Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
Agree Realty (NYSE:ADC) was downgraded by analysts at BTIG Research from a “buy” rating to a “neutral” rating.The current price is $76.75.
Illinois Tool Works (NYSE:ITW) was downgraded by analysts at Bank of America Co. from a “neutral” rating to an “underperform” rating. They now have a $220.00 price target on the stock. This represents a 8.3% downside from the current price of $239.94.
Marvell Technology (NASDAQ:MRVL) was downgraded by analysts at Cantor Fitzgerald from an “overweight” rating to a “neutral” rating. They now have a $60.00 price target on the stock. This represents a 9.2% upside from the current price of $54.93.
Myriad Genetics (NASDAQ:MYGN) was downgraded by analysts at Wells Fargo & Company from an “overweight” rating to an “equal weight” rating. They now have a $6.00 price target on the stock. This represents a 18.1% upside from the current price of $5.08.
Teradata (NYSE:TDC) was downgraded by analysts at Northland Securities from an “outperform” rating to a “market perform” rating. They now have a $21.00 price target on the stock. This represents a 6.4% downside from the current price of $22.44.
Vertex Pharmaceuticals (NASDAQ:VRTX) was downgraded by analysts at Wolfe Research from an “outperform” rating to a “peer perform” rating.The current price is $442.38.
Bright Minds Biosciences (NASDAQ:DRUG) is now covered by analysts at Chardan Capital. They set a “buy” rating and a $80.00 price target on the stock. This represents a 164.2% upside from the current price of $30.28.
Evolution Petroleum (NYSE:EPM) is now covered by analysts at Alliance Global Partners. They set a “buy” rating and a $5.70 price target on the stock. This represents a 37.7% upside from the current price of $4.14.
Praxis Precision Medicines (NASDAQ:PRAX) is now covered by analysts at Chardan Capital. They set a “buy” rating and a $80.00 price target on the stock. This represents a 125.4% upside from the current price of $35.50.
Xenon Pharmaceuticals (NASDAQ:XENE) is now covered by analysts at Chardan Capital. They set a “buy” rating and a $55.00 price target on the stock. This represents a 54.2% upside from the current price of $35.67.
Sign up for MarketBeat All Access to gain access to MarketBeat’s full suite of research tools:
Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat’s trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what’s happening in the market right now with MarketBeat’s real-time news feed. Export data to Excel for your own analysis.
